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abstract: Although selection of chromosomally normal embryos has the potential to improve outcomes for patients undergoing IVF,
the clinical impact of aneuploidy screening by ﬂuorescence in situ hybridization (FISH) has been controversial. There are many putative expla-
nations including sampling error due to mosaicism, negative impact of biopsy, a lack of comprehensive chromosome screening, the possibility
of embryo self-correction and poor predictive value of the technology itself. Direct analysis of the negative predictive value of FISH-based
aneuploidy screening for an embryo’s reproductive potential has not been performed. Although previous studies have found that cleavage-
stage FISH is poorly predictive of aneuploidy in morphologically normal blastocysts, putative explanations have not been investigated. The
present study used a single nucleotide polymorphism (SNP) microarray-based 24 chromosome aneuploidy screening technology to re-evalu-
ate morphologically normal blastocysts that were diagnosed as aneuploid by FISH at the cleavage stage. Mosaicism and preferential segre-
gation of aneuploidy to the trophectoderm (TE) were evaluated by characterization of multiple sections of the blastocyst. SNP microarray
technology also provided the ﬁrst opportunity to evaluate self-correction mechanisms involving extrusion or duplication of aneuploid
chromosomes resulting in uniparental disomy (UPD). Of all blastocysts evaluated (n ¼ 50), 58% were euploid in all sections despite an aneu-
ploid FISH result. Aneuploid blastocysts displayed no evidence of preferential segregation of abnormalities to the TE. In addition, extrusion or
duplication of aneuploid chromosomes resulting in UPD did not occur. These ﬁndings support the conclusion that cleavage-stage FISH tech-
nology is poorly predictive of aneuploidy in morphologically normal blastocysts.
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Introduction
Development of new assisted reproductive technologies has improved
the success of IVF. However, only  13% of embryos selected for
transfer implant and develop into a healthy infant (Centers for
Disease Control and Prevention, 2008). One potential factor account-
ing for the failure of the selected embryos to implant is aneuploidy.
Fluorescence in situ hybridization (FISH) was among the ﬁrst and has
been the most widely used technology to screen for aneuploidy in
human embryos. Initially FISH was employed because it can be
rapidly performed on single cells at interphase. However, limitations
exist, including the inability to comprehensively diagnose the abnorm-
alities of all 24 chromosomes, and the lack of a clinically meaningful
beneﬁt in many randomized clinical trials (reviewed in Fritz, 2008).
Poor clinical performance could be attributed to the embryonic chro-
mosomal mosaicism that is present on Day 3 of development (when
FISH is typically performed). Another signiﬁcant limitation is the lack of
a clinical trial to determine the predictive value of an abnormal FISH
result. No study has ever documented that embryos designated as
abnormal by FISH actually have little or no potential to become a
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a difﬁcult dilemma: what should be done when an embryo blastulates
normally, but has been designated as abnormal by cleavage-stage
FISH?
Previous studies have determined the prevalence of euploidy in
embryos designated as abnormal by cleavage-stage FISH and found
that it varied from 10 to 71% (Li et al., 2005; Munne et al., 2005;
Fragouli et al., 2008; Barbash-Hazan et al., 2009). Discrepant results
have been attributed to mosaicism or embryo self-correction.
However, previous studies have not systematically veriﬁed whether
any self-correction actually occurs, and a recent study indicates that
cleavage-stage mosaicism may be signiﬁcantly overrepresented by
FISH-based analyses (Treff et al., 2010a). New technologies, such as
DNA microarray-based aneuploidy screening, that incorporate both
chromosome copy number (CN) analysis and single nucleotide
polymorphism (SNP) genotyping in parallel (Vanneste et al., 2009;
Johnson et al., 2010; Treff et al., 2010b) may provide the ﬁrst oppor-
tunity to investigate multiple explanations for the differences observed
between cleavage-stage FISH and blastocyst reanalysis results.
Treff et al. (2010b) have demonstrated in a randomized and blinded
fashion the ability to accurately identify aneuploidy of all 24 chromo-
somes using an SNP microarray-based method. Single cells from cell
lines with known abnormalities were diagnosed with 98.6% accuracy
and with no false positive aneuploidy diagnoses. Furthermore, SNP
microarray-based 24 chromosome aneuploidy screening has been
evaluated in a prospective non-selection randomized clinical trial
(Scott et al., 2008), and demonstrated a high negative and positive pre-
dictive value for embryo reproductive potential. Therefore, SNP
microarray-based 24 chromosome aneuploidy screening technology
can be used to accurately predict the chromosomal complement of
blastocysts reanalyzed after being designated as aneuploid by cleavage-
stage FISH.
This study not only contributes additional reanalysis results using a
clinically validated comprehensive aneuploidy screening technology,
but also provides the ﬁrst opportunity to investigate putative self-
correction mechanisms including embryonic mosaicism, preferential
segregation of chromosomal abnormalities to the trophectoderm
(TE) and extrusion or duplication of aneuploid chromosomes resulting
in uniparental disomy (UPD).
Materials and Methods
Experimental design
SNP microarray-based 24 chromosome aneuploidy screening technology
was used to reassess embryos previously diagnosed as aneuploid and to
evaluate mosaicism, conﬁnement to the TE and extrusion or duplication
of aneuploid chromosomes. Embryos that developed to morphologically
normal blastocysts, and that were given an aneuploid FISH diagnosis
from the cleavage-stage blastomere biopsy, were reanalyzed by SNP
microarray-based 24 chromosome aneuploidy screening after preparing
the embryo into three TE and one inner cell mass (ICM) sections. Mosai-
cism, preferential segregation to the TE layer and chromosome extrusion
or duplication resulting in uniparental isodisomy (UPID), were all investi-
gated as possible explanations for euploid observations. All materials
were obtained and evaluated with informed patient consent and under
Institutional Review Board approval.
Embryos
As a component of clinical care, a single blastomere was biopsied from
embryos and underwent FISH-based preimplantation genetic diagnosis
for aneuploidy screening (PGD-AS) due to repeated implantation failure,
recurrent pregnancy loss or advanced maternal age. Embryos diagnosed
as aneuploid by single blastomere FISH and that developed into morpho-
logically normal blastocysts, as deﬁned by Gardner and Schoolcraft,
(1999), were cryopreserved and donated for research. A total of 50
embryos were evaluated from 24 patients. The mean maternal age was
35.1+4.1 years.
Cell lines
Human B-lymphocytes from patients with known UPID were purchased
from the Coriell Cell Repository (CCR, Camden, NJ) and cultured as rec-
ommended by CCR (repository numbers GM15603 and GM11496). Five
cells (to model the minimum number of cells represented in blastocyst
sections described below) were removed from media and picked up
with a 275 mm micropipette under a dissecting microscope, and placed
in a nuclease-free 0.2 ml polymerase chain reaction (PCR) tube in 1 ml
of media for immediate lysis (as described below). Cell lysates underwent
subsequent whole genome ampliﬁcation (WGA) and 262 K microarray
analysis as previously described (Treff et al., 2010b). In order to determine
the ability of SNP microarray-based 24 chromosome aneuploidy screening
to detect aneuploidy within a mosaic blastocyst biopsy, samples from a
normal female and a normal male cell line were purchased from the
CCR (Camden, NJ) and cultured as recommended by CCR (repository
numbers GM00321 and GM00323). Samples were mixed at levels of 0,
25, 40, 60, 75 and 100% of one sample relative to the other. The ability
to detect a monosomy X within a mixture of male (monosomy X) and
female (disomy X) samples was evaluated as previously described (Treff
et al., 2010b).
Fluorescence in situ hybridization
Blastomere biopsy was conducted on Day 3 of embryonic development as
previously described (Csokmay et al., 2009). Biopsied embryos were
rinsed repeatedly and placed individually in extended microdroplet
culture for potential embryo transfer pending FISH analysis. The isolated
blastomeres were individually placed on a glass slide, pre-incubated in a
hypotonic solution and ﬁxed using 3:1 methanol:acetic acid solution.
Two rounds of FISH were performed on ﬁxed blastomeres using probes
speciﬁc for chromosomes 13, 15, 16, 17, 18, 21, 22, X and Y (Vysis,
Downer’s Grove, IL). The slides were analyzed using an automated
Olympus BX61 ﬂuorescence microscope (Center Valley, PA). The
images were captured using Cytovision probe software (Applied Imaging
Corp., San Jose, CA). Reconﬁrmation of inconclusive results was con-
ducted as previously described (Colls et al., 2007).
SNP microarray-based 24 chromosome
aneuploidy screening
Only embryos that had been previously diagnosed as abnormal by FISH
and that fully blastulated were selected for reanalysis. Embryos chosen
for reanalysis were slow-thawed and biopsied as previously described
with slight modiﬁcations (Treff et al., 2010c). Instead of performing a
single biopsy, four separate sections were processed (three individual TE
samples and one ICM sample) to evaluate mosaicism and potential con-
ﬁnement to the TE. Brieﬂy, TE biopsy was performed by opening a hole
in the zona pellucida with a series of single, millisecond pulses by a 1–
3 mm diode laser from an infrared 1.48 pulse duration at 100% power
(Hamilton-Thorne Research, Beverly, MA). Sections of herniating TE
cells were aspirated individually into a TE biopsy pipette (Humagen,
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pulses at the constricted area of cells at the end of the pipet. The biopsied
pieces of TE tissue underwent three sequential washes in a hypotonic sol-
ution and were placed intact in nuclease-free 0.2 ml PCR tubes (Ambion,
Austin, TX). A fourth sample consisting of cells comprising the ICM, was
separated from the zona pellucida and placed into a PCR tube, as
explained above. ICM was judged as free from TE cells by morphological
assessment by an embryologist. In addition, each sample consisted of  5
cells, as judged by an embryologist. Immediately following biopsy, all cells
were lysed, as previously described (Cui et al., 1989), and frozen at
2208C for SNP microarray-based 24 chromosome aneuploidy screening
analysis. All sample tubes were coded by an embryologist and blinded
for downstream microarray analysis.
All four sections taken from a blastocyst underwent SNP microarray-
based 24 chromosome aneuploidy screening, as previously described
(Treff et al., 2009). Brieﬂy, WGA was conducted according to the rec-
ommended protocol beginning with library preparation (GenomePlex
WGA4, Sigma Aldrich, St Louis, MO). WGA DNA was puriﬁed using
the GenElute PCR Puriﬁcation Kit as recommended (Sigma Aldrich).
A WGA yield of 2.5 mg was considered successful ampliﬁcation. Two-
hundred and ﬁfty nanograms of puriﬁed WGA DNA were processed
through the NspI GeneChip Mapping 262 K microarray as recommended
by the manufacturer (Affymetrix, Santa Clara, CA). Aneuploidy screening
was performed by CN analysis of the microarray data using the Copy
Number Analysis Tool (CNAT) version 4.0.1 (Affymetrix). The microarray
data discussed in this publication have been deposited in NCBI’s Gene
Expression Omnibus and are accessible through GEO Series accession
number GSE18932 (http://www.ncbi.nlm.nih.gov/geo).
Data analysis
Microarray reanalysis consistency with FISH
Embryos were selected for reanalysis based on one of three FISH diagnos-
tic categories, (i) a single monosomy, (ii) a single trisomy or (iii) at least
two or more abnormalities (complex aneuploid). This selection provided
an opportunity to determine whether one type of FISH-based diagnosis
was more prone to inconsistency with SNP microarray-based 24 chromo-
some aneuploidy screening reanalysis results. An ANOVA was performed
to determine whether there were differences in consistencies between
these three categories. Alpha was set at 0.05.
After each embryo section diagnosis was made by SNP microarray-
based 24 chromosome aneuploidy screening, samples were decoded to
reveal the relationship between each section. All evaluable sections from
the same embryo were compared for similarity within the microarray
data and against the original blastomere FISH result. Results were categor-
ized into two main and four subset groups (Fig. 1). Results were ﬁrst cate-
gorized as ‘euploid’ (all sections) or ‘aneuploid’ (at least one section). The
aneuploid category was further separated into two subsets; either ‘consist-
ent’ or ‘inconsistent’ with FISH when considering only the chromosomes
evaluated by FISH. ‘Consistent’ aneuploid results were either consistent in
all four sections or only consistent in some but not all of the sections
(mosaic). Microarray ‘aneuploidy’ results that were ‘inconsistent’ with
FISH had either the same diagnosis in all sections or had more than one
diagnosis (mosaic).
Mosaicism and TE conﬁnement
SNP microarray-based 24 chromosome aneuploidy screening diagnosis
was conducted on embryos that were separated into three sections con-
taining TE cells and one section containing ICM cells. Evaluation of the rate
of aneuploidy in TE sections was compared with the aneuploidy rate in
ICM sections using a 2 × 2 contingency table of x
2 analysis. Alpha was
set at 0.05. Mosaic blastocysts that included an aneuploidy consistent
with the original FISH result were also speciﬁcally evaluated for preferential
segregation of abnormalities to the TE.
Monosomy and trisomy rescue
Duplication (monosomy rescue) or extrusion (trisomy rescue) of an aneu-
ploid chromosome represents an additional mechanism of self-correction
and could be identiﬁed by the presence of UPD. All disomies derived from
duplication of a monosomic chromosome would result in UPID, where
both chromosomes have identical DNA sequences. In addition, a pro-
portion of disomies derived from extrusion of a trisomic chromosome
would result in UPID (Engel and Antonarkis, 2002). One hallmark of chro-
mosomal UPID is a lack of any heterozygous SNPs (Suela et al., 2007). The
absence or loss of heterozygosity (LOH) of SNPs in a chromosome was
therefore used to indicate the presence of UPID. The chromosome-
speciﬁc probability of LOH was calculated by averaging the probabilities
assigned to each SNP for a given chromosome using CNAT 4.0 (Affyme-
trix Inc.). A DM algorithm setting of 0.01 was the only change to the
default settings for analysis of LOH by CNAT 4.0.
In order to establish a mean LOH probability threshold for identifying
the presence of UPID in only a few cells (i.e. an embryo TE or ICM
section), four replicates of ﬁve cells each, from two different cell lines,
with known UPID chromosomes (described above) were evaluated.
LOH probability distributions of chromosomes known to be UPID in
origin (positive controls), and of chromosomes known to be disomic
with bi-parental inheritance (negative controls), were used to establish a
UPID LOH probability threshold with 100% sensitivity and speciﬁcity.
Chromosomes from embryo TE and ICM sections that reached the
deﬁned threshold were assigned an origin of UPID. UPID was evaluated
for each of the chromosomes that were originally given a monosomy or
a trisomy diagnosis by FISH but were shown to be disomic by microarray.
In addition, the overall prevalence of UPID was determined by evaluating
LOH probabilities in all copy neutral autosomes (i.e. CN of two) as
assessed by SNP microarray-based 24 chromosome aneuploidy screening.
The LOH probability of microarray copy neutral chromosomes was com-
pared with UPID positive and negative control chromosomes using an
ANOVA. Alpha was set at 0.05.
Results
Microarray reanalysis consistency with FISH
SNP microarray-based 24 chromosome aneuploidy screening demon-
strated the ability to detect aneuploidy in samples that possess more
Figure 1 Diagram of categorical results of microarray reanalysis of
morphologically normal blastocysts given a FISH-based aneuploidy
diagnosis at the cleavage stage.
592 Northrop et al.than 25% aneuploidy (Fig. 2) indicating that the present technology is
capable of detecting mosaicism when as few as 2 of the typical 5 cells
within a blastocyst biopsy contain the same aneuploidy. Successful
ampliﬁcation and SNP microarray-based 24 chromosome aneuploidy
screening were obtained for 192 of the 200 blastocyst sections pro-
cessed (96%). After decoding identities for each section, data were
assembled according to the embryo from which it came and com-
pared with the original FISH result (Table I). Overall, reanalysis by
microarray diagnosed 29 embryos as normal (58%) in all evaluable
sections (Fig. 3A). Twenty-four percent of the embryos were aneu-
ploid for chromosomes different from the original FISH result. Ten
percent of the embryos were consistent with the original FISH
Figure 2 Results of microarray-based aneuploidy screening of mixtures of normal female (46,XX) and a normal male (46,XY) samples indicating a
sensitivity of aneuploidy detection (monosomy X) at .25%. As shown, 0–25% male samples (A, B) did not detect monosomy X whereas for 40, 60,
75 and 100% (C–F) monosomy X was detected (right hand column).
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Table I Diagnosis of all cleavage-stage FISH abnormal embryos and reanalysis results of SNP microarray-based
24 chromosome aneuploidy screening at the blastocyst stage.
Microarry blastocyst
Embryo FISH aneuploidy TE TE TE ICM
Normal
1 213, 216, 21 7 ————
2X , 217, 221, 22 2 ————
3 +2 1 ————
4 216, 21 8 ————
5 21 8 ————
8 22 2 ————
9 +1 6 ————
10 +1 8 ————
15 21 8 ————
16 +13, 217, 21 8 ————
17 +13, +18, +2 2 ————
20 22 1 ————
21 217, 218, 22 2 ————
23 21 3 ————
24 21 6 ————
25 213, 21 5 ————
26 21 7 ————
27 22 1 ————
28 21 7 ————
29 +13 NA — NA —
30 +15, +2 2 ————
32 +1 8 ————
34 +2 1 ————
37 +1 3 ————
38 +2 1 ————
47 213, 216, 221, 222, +1 8 ————
48 215, 217, +1 8 ————
49 215, 217*, +1 8 ————
50 216, +13, +2 2 ————
Different abnormality than FISH
18 215, 217 215 215 215 215
19 X NA +11 +11 +11
31 +13 +2 +2N A+2
33 +18 24— 24 24
35 +21 — — 214, 218 —
36 +13 — +16 — —
39 +13, +16 26 26, 216 NA NA
42 216, 222, +13, +15 222 222 222 222
43 221, 222, +18 +15, +17, +18 +15, +17, +18 +18 +15, +17, +18
44 216, +22 +22 — — —
45 XYY, 216, +21 218, +21 218, +21 211, 218, +21 218, +21
46 221, +13, +22 — +22 +22 —
Continued
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Table I Continued
Microarry blastocyst
Embryo FISH aneuploidy TE TE TE ICM
Same abnormality as FISH
6 22 2 ———222
7 216 216 216 216 216
11 +21 +21 +21 +21 +21
12 +16 +16 +16 +16 +16
13 +15 +15 +15 +15 +15
14 222 NA 222 222 222
22 215 215 215 — 215
40 +16 +16 +16 +5, 29N A
41 +15 +15 — +15 +15
Legend: normal diagnosis (46,XX or XY) is represented by —. ‘Same as FISH’ indicates that at least one microarray result was consistent with the original FISH diagnoses. Abbreviations:
TE, trophectoderm; ICM, inner cell mass; NA, no ampliﬁcation; *, nullisomy.
Figure 3 Results of microarray for (A) all blastocysts (n ¼ 50), (B) blastocysts with a single monosomy diagnosis by FISH, (C) blastocysts with a
single trisomy diagnosis by FISH or (D) blastocysts with two or more abnormalities diagnosed by FISH.
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were consistent with the original FISH result in at least one section
evaluated by microarray.
A subset analysis separated out the FISH results into three cat-
egories: monosomy, trisomy or complex aneuploid (Fig. 3B). Of
those embryos diagnosed as monosomy by the original FISH analysis,
65% were euploid for all 24 chromosomes in all four sections evalu-
ated by microarray. In another 7%, microarray showed a consistent
abnormality in all evaluable sections. However, the abnormalities
observed were different from the original FISH result. The remaining
28% of embryos showed a result consistent with FISH in one or
more sections evaluated by microarray (Fig. 3B).
In those embryos called trisomy by FISH, 47% were euploid for all
24 chromosomes in all sections evaluated by microarray. In another
23%, microarray showed a consistent abnormality in all evaluable sec-
tions. However, the abnormalities observed were different from the
original FISH result. The remaining 30% of embryos showed a consist-
ent result with FISH in one or more sections evaluated by microarray
(Fig. 3C).
Finally, of those embryos called complex aneuploid by FISH, 63%
were euploid for all 24 chromosomes in all sections evaluated by
microarray. In the remaining 37% of complex aneuploid FISH
embryos, microarray showed a consistent abnormality in all evaluable
sections. However, the abnormalities observed were different from
the original FISH result. Remarkably, there were no complex aneu-
ploid FISH embryos that were consistent with one or more sections
evaluated by microarray (Fig. 3D). Embryos labeled by FISH as
complex aneuploid were microarray normal more often than those
that were trisomic or monosomic (P , 0.006).
Examination of self-correction mechanisms:
mosaicism and TE conﬁnement
The rate of mosaicism observed by microarray reanalysis of multiple
sections of 50 blastocysts was 24% (Fig. 4). The remaining 76% of blas-
tocysts displayed the same euploid or aneuploid diagnosis in all evalu-
able sections (Fig. 4). Eight of the 12 mosaic embryos were entirely
inconsistent with the original FISH result (Table I). Of the four
mosaic embryos that had abnormalities possibly consistent with the
original FISH result, only embryo number 6 (Table I) displayed prefer-
ential segregation of the abnormality. However, the abnormality was
present in the ICM and not the TE. The ICM sample from one
embryo (number 40, Table I) did not amplify. The other two
embryos (numbers 22 and 41, Table I) showed no preferential segre-
gation since abnormalities were found in both the TE and ICM. Aneu-
ploidy was observed in 15 of 48 ICM samples (31%) and 46 of 144 TE
samples (32%), showing no indication of preferential aneuploid cell
migration to the TE layer (P ¼ 0.9).
Monosomy and trisomy rescue
Monosomyandtrisomyrescuehavebeenproposedasapossiblemech-
anismofembryoself-correction.ThiswouldresultinUPIDinallmonos-
omy cases through a duplication event and in a proportion of trisomy
rescue cases by extruding the extra chromosome. Cell lines with
known chromosomal UPID were analyzed to establish a UPID-speciﬁc
LOH probability threshold. Examples of LOH proﬁles are shown in
Fig. 5, illustrating a marked reduction in the number of SNPs (blue
dots) below the LOH probability of 1 for true UPID chromosomes
(Fig. 5A and B, chromosomes 7 and 8, respectively). Chromosomes
known to be UPID in origin (UPID positive controls, n ¼ 8) displayed
an average LOH probability of 0.998+0.002 (Fig. 6). Copy neutral
autosomes with bi-parental inheritance (UPID negative controls, n ¼
168) displayed an average LOH probability of 0.206+0.090 (Fig. 6).
As a result of these observations, a UPID-speciﬁc LOH probability
thresholdof0.996wasusedtosystematicallyanalyzechromosomesdiag-
nosed asmonosomyortrisomybycleavage-stageFISHbutsubsequently
shown at the blastocyst stage to be diploid by microarray. Examples of
microarray results for embryos with either a FISH-based monosomy
(Fig. 5C) or trisomy (Fig. 5D) illustrate a lackof differences in LOH prob-
abilities.Indeed,allsuchchromosomesfailedtoexceedtheUPID-speciﬁc
LOH probability threshold of 0.996 (Fig. 6). Moreover, all of the UPID
negativecontrolchromosomesandtheaneuploidFISH/disomymicroar-
ray chromosomes were signiﬁcantly different from the UPID positive
controlchromosomes(P , 0.001).Examplesofamicroarraymonosomy
and trisomy are also presented. As expected, the monosomy chromo-
some (Fig. 5E) displayed a distinguishable LOH probability similar to
known UPID chromosomes and consistent with previously published
results on single cells (Treff et al., 2010b). In addition, a trisomy chromo-
some(Fig.5F)displayedadistinguishableLOHprobabilityconsistentwith
previously published single cell results (Treff et al., 2010b). Not a single
FISH aneuploid chromosome displayed UPID in any of the 192 samples
from 50 blastocysts. Additional analysis of all microarray disomy auto-
somes indicated that none (0 of 4149) were UPID in origin.
Discussion
Several reports have commonly found euploidy in blastocysts that
were previously diagnosed as aneuploid at the cleavage stage by
Figure 4 The rate of mosaicsm in all embryos diagnosed as abnor-
mal by FISH and reanalyzed in four separate blastocyst sections by
microarray. Blastocysts are represented as having 1 diagnosis (no
mosaicism) or having 2, 3 or 4 different diagnoses in the same
embryo (mosaicism). Numbers inside each bar represents the
number of embryos.
596 Northrop et al.Figure 5 Representative SNP microarray-based 24 chromosome aneuploidy screening images showing microarray results for CN and LOH
probability. Microarray CN and LOH probability results for 5 cells from cell lines that possess UPID for either chromosome 7 (A)o r8( B),
where the CN equals 2 and the average LOH probability is greater than 0.996. Microarray results for a TE sample from embryo #24 (C) originally
given a cleavage-stage FISH monosomy diagnosis for chromosome 16, and embryo #38 (D), originally given a cleavage-stage FISH diagnosis of
trisomy 21. In both cases, the CN equals 2 and the average LOH probability equals less than 0.996 ( 0.2). Microarray results for a TE sample
from embryo 7 (E), given a monsomy 16 diagnosis by FISH and microarray. The chromosome 16 CN equals 1 and the LOH probability is similar
to UPID chromosomes. Microarray results for a TE sample from embryo 13 (F), given a trisomy 15 diagnosis by FISH and microarray.
The chromosome 15 CN equals 3 and LOH equals less than 0.996. Red chromosome numbers indicated chromosomes of interest.
Abbreviations: chr, chromosome.
Cleavage-stage FISH poorly predicts blastocyst aneuploidy 597FISH (Li et al., 2005; Munne et al., 2005; Fragouli et al., 2008; Barbash-
Hazan et al., 2009) and in effect, this study reafﬁrms these obser-
vations. The authors of these studies elected to conclude that incon-
sistent results may be due to mosaicism, self-correction or technical
error. Of those explanations, only one study explored the possibility
of self-correction by examining preferential segregation of abnormal-
ities to the TE in separate TE and ICM samples (Fragouli et al.,
2008). However, that study found 100% consistency between the
TE and ICM, and therefore provided no evidence to evaluate the etiol-
ogy of the discrepancies through mosaicism or TE conﬁnement.
Indeed, none of the previous studies describing inconsistent results
between the cleavage and blastocyst stages of development establish
evidence for any of the proposed explanations.
The study presented here speciﬁcally evaluated the differences
between the cleavage and blastocyst stages of development by inves-
tigating possible explanations of inconsistencies including mosaicism,
TE conﬁnement and self-correction through monosomy/trisomy
rescue mechanisms. Preferential segregation or conﬁnement of aneu-
ploidy to the TE would result in a euploid fetus with placental mosai-
cism. Indeed, placental mosaicism has been well documented
(Kalousek and Dill, 1983; Stetten et al., 2004) and is the primary
experimental data used to support the concept of aneuploid conﬁne-
ment to the TE in human embryos. Interestingly, many cases of con-
ﬁned placental mosaicism have been identiﬁed as meiotic in origin
(Robinson et al., 1997). Nonetheless, experimental evidence to
support TE conﬁnement of aneuploidy in the embryo is lacking
(Evsikov and Verlinsky, 1998; Magli et al., 2000; Fragouli et al., 2008)
and no preferential segregation of aneuploid cells to the TE was
observed in our study.
Extrusion of an extra chromosome to rescue a trisomy or dupli-
cation of a chromosome to rescue a monosomy may also explain
differences observed between the cleavage and blastocyst stages of
development. By deﬁnition, all monosomy duplications would result
in UPID with two copies of the same parental chromosome being
present. A trisomy rescue event would lead to disomic chromosomes
with bi-parental inheritance two-thirds of the time and UPD one-third
of the time. Depending on the mechanism leading to the trisomy (i.e.
non-disjunction during meiosis I or II, or premature separation of sister
chromatids), a rescue event could either lead to uniparental heterodis-
omy or UPID (Engel and Antonarkis, 2002). Uniparental heterodisomy
does not lead to long contiguous stretches of homozygosity and would
require simultaneous analysis of parental SNPs in order to be ident-
iﬁed. In the work reported here, the technical ability to accurately
identify UPID in cells known to possess UPID chromosomes was
established (Fig. 5). Subsequent use of the validated UPID detection
technique on 4149 disomy autosomes from 192 sections of 50
human blastocysts demonstrated a 0% rate of UPID. Moreover, this
rate of UPID was also observed after speciﬁc evaluation of chromo-
somes predicted to be a monosomy or trisomy by FISH at the clea-
vage stage and subsequent prediction of disomy in all sections of
the blastocyst. This result indicates that monosomy/trisomy rescue
resulting in UPID is not the explanation for euploid blastocyst develop-
ment from a cleavage-stage embryo diagnosed as aneuploid by FISH.
Other explanations for the discrepancies observed between
cleavage-stage FISH and blastocyst stage microarray analyses may
include apoptotic elimination of aneuploid cells. Although this mechan-
ism cannot be ruled out in the present study, its existence has yet to
be experimentally demonstrated elsewhere. Another possible expla-
nation may be that cells with reciprocal abnormalities from mitotic
non-disjunction are present within the same blastocyst biopsy resulting
in a euploid diagnosis by microarray. However, there are many
reasons why this is highly unlikely. First, it is well established that
human aneuploidy primarily originates from maternal meiosis
(Hassold and Hunt, 2001), which has been supported by direct analy-
sis of maternal meiosis in polar bodies (Kuliev et al., 2005). As a result,
the majority of abnormalities observed by FISH at the cleavage stage
should be present within the entire embryo (constitutive). Moreover,
in some studies, mitotic non-disjunction is the least frequently
observed form of mosaicism. For example, Delhanty and Handyside
(1995) noted that, with respect to FISH-based analyses, embryos
with predicted mitotic errors typically do not display complementary
(reciprocal) abnormalities in other cells. Indeed, observation of reci-
procal abnormalities is considered as evidence necessary to demon-
strate the presence of mitotic non-disjunction. By this deﬁnition,
comparative genomic hybridization-based methods (Voullaire et al.,
2000; Wells and Delhanty, 2000) also found that mitotic non-
disjunction was the least frequently observed form of mitotic mosai-
cism. Non-reciprocal abnormalities would indeed be detected by
the methods used in the present study as long as more than 25% of
the cells within the biopsy (i.e. two of ﬁve cells) possess the same
aneuploidy (Fig. 2).
The argument can still be made that the discrepancies between
cleavage-stage FISH results and blastocyst reanalysis results are
Figure 6 Deﬁning UPID by LOH. Lymphocyte controls consist of 5
cells per sample. Box plots of distributions are shown for positive
control chromosomes known to be UPID (n ¼ 8), UPID negative
control chromosomes from the same samples and known to be
normal disomy (n ¼ 168), and blastocyst microarray disomy chromo-
somes originally diagnosed as monosomy (n ¼ 132), or trisomy
(n ¼ 72) by cleavage-stage FISH. *Indicates a signiﬁcantly different
average LOH probability of the UPID positive control chromosomes
compared with either the UPID negative control chromosomes or
the aneuploid FISH/disomy microarray chromosomes (P , 0.001).
598 Northrop et al.largely due to true cleavage-stage mosaicism. This is supported by a
high rate of mosaicism observed in many previous studies where mul-
tiple blastomeres from the same embryo have been studied. Although
the present study cannot rule out this possibility, a recent study
speciﬁcally evaluated the alternative interpretation of previous ﬁndings;
that FISH may overestimate true cleavage-stage mosaicism (Treff et al.,
2010a). In that study, blastomeres from the same embryos were
blinded and randomized to analysis by two technologies; FISH and
microarray-based aneuploidy screening. FISH estimated mosaicism
to be present in 100% of the embryos evaluated. In contrast, micro-
array estimated, in the same embryos, mosaicism to be present in
only 31% (P ¼ 0.0005), despite evaluating more chromosomes per
cell and more cells per embryo. In addition, the present study estab-
lished the ability to detect mosaicism of above 25% within each blas-
tocyst biopsy. Evaluation of four biopsies from each embryo also
demonstrated that only 24% of blastocysts displayed mosaicism and
that only 8% of embryos were mosaic for aneuploidy consistent
with the original cleavage-stage FISH result. Together, these ﬁndings
indicate that mosaicism is not the primary explanation for discrepan-
cies between the cleavage-stage FISH result and the blastocyst stage
reanalysis result.
There are now numerous studies indicating aneuploidy diagnosis in
morphologically normal blastocysts is poorly predicted by cleavage-
stage FISH. We have provided additional understanding to these ﬁnd-
ings by speciﬁcally evaluating mosaicism, conﬁnement of aneuploidy to
the TE and chromosome duplication or extrusion resulting in UPID as
viable explanations. Given that many morphologically normal blasto-
cysts diagnosed as aneuploid by cleavage-stage FISH are euploid,
and that a blastocyst euploid diagnosis has positive predictive value
for reproductive competence (Scott et al., 2008), it is possible that
FISH-based aneuploidy screening on cleavage-stage embryos results
in the erroneous disposal of reproductively competent blastocysts.
At a minimum, retesting of morphologically normal blastocysts that
develop despite an aneuploid cleavage-stage FISH diagnosis is strongly
recommended.
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